Mammalian target of rapamycin and head and neck squamous cell carcinoma
about
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine.Long-term stimulation of areca nut components results in increased chemoresistance through elevated autophagic activity.mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer.Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions.Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo.Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation.Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression.Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
P2860
Q35106460-BE75342A-8B0C-48B8-8577-8072A003A7D2Q35954892-C6332FDE-D9E2-4A70-8EBD-3B15C4529C6CQ36879225-735F0046-F0FC-4156-8BFD-28CB189C0D2EQ37269265-1A8135BE-8348-4C5C-8602-D6AC6E7707A2Q38023238-8F3FC4DC-FCF9-4596-B9CC-F1DFBB3F1D5CQ38929614-CD7F9D3E-ECAA-46A1-8CB5-4049C774208AQ39135798-93348D3E-441E-4CDA-99C1-0FFA982179BFQ39420117-96574B92-15DA-4CD0-8F05-6D14FC5152D1Q39623358-D8F2B6C2-9733-4AE5-A2DE-57388C523E2FQ42093380-E7CDBFD8-7CEA-42C2-86D1-C0BA4582FA5CQ46238476-DC243D38-4BF2-4F02-8B57-5F5D1A87416FQ47232136-29D0315C-21BF-4A3E-9358-52DF3400570FQ49886956-115008A8-2F78-4837-A002-EF820B84A876Q57450687-E4E5AA91-7A3A-4FA8-9629-3202DE5270C5
P2860
Mammalian target of rapamycin and head and neck squamous cell carcinoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@ast
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@en
type
label
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@ast
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@en
prefLabel
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@ast
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@en
P2093
P2860
P921
P356
P1433
P1476
Mammalian target of rapamycin and head and neck squamous cell carcinoma
@en
P2093
P2860
P2888
P356
10.1186/1758-3284-3-22
P5008
P577
2011-04-24T00:00:00Z
P5875
P6179
1003453019